Biotransformation Products
Biotransformation Products - Related Videos
01:16
Drug Biotransformation: Overview
0 Views •
2023
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28
Drug Biotransformation: Overview
0 Views •
2025
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:19
Factors Affecting Drug Biotransformation: Biological
0 Views •
2025
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity. Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects. Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
01:21
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
0 Views •
2025
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism. The drug's acidity or basicity is essential in determining the metabolic...
11:42
Lentivirus Production
0 Views •
Cited by 43 •
2009
To make lentiviruses, DNA vectors are transfected into human 293 cells. After harvest and concentrating the supernatant, virus titer is determined by fluorescence expression with a flow cytometer.
FAQs
The reaction class determines which parts of the starting molecule are altered. Oxidation, reduction, hydrolysis, and conjugation can each produce different structural changes, affecting the resulting substance’s activity, solubility, or stability. Identifying the reaction type helps researchers connect enzyme behavior with product properties and select conditions suited to a desired conversion.
Even a targeted molecular modification can change how a product behaves. Biotransformation may alter biological activity, solubility, or stability, so product characterization must consider more than chemical identity alone. These property changes are important when evaluating whether a compound is suitable for manufacturing, assessing its behavior during drug metabolism, or determining its usefulness in an engineered system.
Pathway design and process conditions affect the relationship between conversion and performance. Researchers examine how defined biological conditions influence yield, selectivity, and function, then optimize the system toward the intended product outcome. This approach links the arrangement of biological steps and the operating environment to the amount formed and the preference for particular products.
Characterization shows which products form and how their formation relates to pathway design and process conditions. By examining product formation alongside yield, selectivity, and function, researchers can determine whether an engineered system is producing the intended result. The information supports optimization rather than relying only on evidence that the starting compound has been converted.
In drug metabolism studies, the products generated from a starting compound provide information about how biological systems modify it. Because these changes can affect molecular activity, solubility, or stability, analyzing the products contributes to safety assessment. The resulting data help researchers evaluate metabolic outcomes instead of considering only the properties of the original compound.
Bioengineers analyze and optimize these products for several purposes, including producing valuable compounds through biocatalytic manufacturing and supporting biodegradation of environmental contaminants. Product analysis helps determine whether a conversion is useful, selective, and functionally appropriate. It also connects biological pathway design and process conditions with practical outcomes such as improved production or contaminant breakdown.